(Abst.) Immune profiling of a patient w/alemtuzumab-associated PML on: April 10, 2019, 04:24:57 pm #1 From PubMed (April 10, 2019), "Immune profiling of a patient w/alemtuzumab-associated PML": Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy - PubMed A 31-year-old woman affected by multiple sclerosis (MS) experienced generalized tonic-clonic seizures 2 months after the second alemtuzumab cycle. Positive JC virus (JCV)-DNA in cerebrospinal fluid... PubMed · bit.ly Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
